The relation between some parasitological parameters and inflammatory bowel disease infection
Keywords:
inflammatory bowel disease, Giardia lamblia, Entamoeba histolytic, Helicobacter pyloriAbstract
The term inflammatory bowel disease (IBD) refers to several chronic and recurrent inflammatory gastrointestinal disorders.. This current study was included (180) patients aged (15-60) with inflammatory disease of the internal organs who attended Al-Ramadi Teaching Hospital in Anbar Governorate between September 1st of 2021 to the 1st of May 2022. Elected according to the diagnosis of a gastroenterologist. Three groups of samples were created. The first group (60 samples) from patients full of IBD and Lamblia protozoan infection, group II (60 samples) of patients with inflammatory bowel disease and Entamoeba histolytica - infection suffering, and group III (60 samples) for patients with inflammatory internal organ disease and Helicobacter pylori infection. While the control group consisted of (40) healthy individuals of different ages (15-60) years. They did not have a history of inflammatory bowel disease upon examination by gastroenterologist .The present study revealed a statistically significant difference between the cases (all three groups), and as a result, the p-value for the control group was(<0.05).
Downloads
References
Akbarov, A. N., & Xabilov, D. N. U. (2021). The condition of the oral cavity in patients who have had a viral infection COVID-19. International Journal of Health & Medical Sciences, 4(4), 381-383. https://doi.org/10.21744/ijhms.v4n4.1796
Ali O.S .,Shihab A. M., and Yahya J. S. (2018).Relationship between Entamoeba histolytica and Fecal Calprotectin, Egyptian Journal of Medical Microbiology . 27 ( 2) : 49-56
Allen J., and Maizels R. (2011).Diversity and dialogue in immunity to helminths. Nat. Rev. Immunol.,11: 375 – 388.
Anim-Baidoo,I. ; Narh,C.A. ; Oddei,D. ; Brown,C.A. ; Laryea,C.E. ; Bandoh,B. ; Donkor,E.S. ; Armah,G. ; Adjel,A.A. ; Adjel,D.N. ; Ayeh-Kumi,P.F. ; Gyan,B.A.(2016). Giardia lamblia infections in children in Ghana. Pan African medical journal .19(86):1-12.
Asakura K., Nishiwaki Y., Inoue N., Hibi T, Watanabe M., Takebayashi T.(2009). Prevalence of ulcerative colitis and Crohn’s disease in Japan. J Gastroenterol ;44:659‑65
Babaei Z., Malihi N., Zia-Ali N., Sharifi I.,Mohammadi, M.,Kagno M., Eckmann L., Singer S., Solaymani-Mohammadi S. (2016).Adaptive immune response in symptomatic and asymptomatic enteric protozoal infection: Evidence for a determining role of parasite genetic heterogeneity in host immunity to human giardiasis. Microbes Infect. 18, 687–695.
Babic E. , Milenko B., Mladen M., Maja K., Mile V., Ante B., Tatjana B.,Danijel P., and Nikica S.,(2016).Prevalence of amebiasis in inflammatorybowel disease in University Clinical Hospital Mostar.SpringerPlus ;5:(1586):2-4.
Brooke M., Melvin D.(2001). Morphology of diagnostic stages of intestinal parasites of human. U.S. department of health and human services, Second Edition.
Cader, M., and Kaser A. (2013). Recent advances in inflammatory bowel disease: mucosal immune cells in intestinal inflammation. Gut 62: 1653-1664.
Castano-Rodríguez N., Kaakoush N., Lee W., and Mitchell H.(2017). Dual role of Helicobacter and Campylobacter species in IBD: a systematic review and meta-analysis. Gut ;66:235-249.
Chin A., Teoh D., Scott K., Meddings J.,Macnaughton W.,and Buret A.( 2002). Strain-dependent induction of enterocyte apoptosis by Giardia lamblia disrupts epithelial barrier function in a caspase-3-dependent manner. Infect. Immun. 70:3673–3680
Emil B. , Milenko B., Mladen M., Maja K., Mile V., Ante ., Tatjana B., Danijel P., and Nikica Š.( 2016). Prevalence of amebiasis in inflammatory bowel disease in University Clinical Hospital Mostar. SpringerPlus .5(1586):1-4
Fink M., and Singer S.( 2017).The intersection of immune responses, microbiota, and pathogenesis in giardiasis. Trends Parasitol. 33, 901–913.
Gerard J .,and Bryan D. (2009)Principles Of Anatomy and Physiology.John Wiley & Sons, Inc.800: 225-5945.
Geremia A., Biancheri P., Allan P., Corazza G., and Sabatino A.( 2014).Innate and adaptive immu¬nity in inflammatory bowel disease. Autoimmun Rev. 13: 3-10.
Hammood A. M ., Ahmed B. A. and Salman Y. J.(2016). Blastocystis hominis Detection among Gastrointestinal Disorders' Patients in Kirkuk Province Using Three Different Laboratory Methods. Int.J.Curr.Microbiol.App.Sci ; 5(7): 883-901.
Hussein H., Manal K., and Akram N.(2017).Potential Benefit of Melatonin as an Adjuvant Therapy in a Sample of Iraqi Patients with Crohn’s Disease: A New Study. AJPS. 17(2).
Imawana R., Smith D., Goodson M.(2020). The relationship between inflammatory bowel disease and Helicobacter pylori across East Asian, European and Mediterranean countries: a meta-analysis. Ann Gastroenterol ;33:485–94.
Jairath, V., and Feagan, B. (2020). Global burden of inflammatory bowel disease. Lancet Gastroenterol. Hepatol. 5 (1), 2–3.
Jolene H. , Sarah A., and Julia W.(2017). Giardiasis and Subsequent Irritable Bowel Syndrome: A Longitudinal Cohort Study Using Health Insurance Data.The Journal of Infectious Diseases.23(215):798-805.
Kabir S.(2004). Detection of Helicobacter pylori DNA in feces and saliva by polymerase chain reaction: a review. Helicobacter; 9: 115-123 .
Karabay O., Tamer A., Gunduz H., Kayas D., Arinc H., and Celebi H.(2004).Albendazole versus metronidazole treatment of adult giardiasis: An open randomized clinical study,” World Journal of Gastroenterology, vol. 10( 8):1215–1217.
Keenan J., Beaugie C., Jasmann B., Potter H., Collett J., and Frizelle F.(2010). Helicobacter species in the human colon. Colorectal Dis; 12: 48-53 .
Kim D., and Cheon J.(2017). Pathogenesis of inflammatory bowel disease and recent advances in biologic therapies. Immune Netw ;17:25-40.
Koontz F. Weinstock J.(1996). The approach of stool examination for parasites. Gastroenterology clinics ; 25(3):435-449.
Li J., Li P., Bai J., Lyu H., Li Y., Yang H., Shen B., Qian J.( 2015). Discriminating potential of extraintestinal systemic manifestations and colonoscopic features in Chinese patients with intestinal Behcet’s disease and Crohn’s disease. Chin Med J (Engl).128: 233–238.
Lisa A., Reynolds B., Brett F. and Rick M.( 2015). MaizelsCohabitation in the Intestine: Interactions among Helminth Parasites, Bacterial Microbiota, and Host Immunity.J Immunolology. 195:4059-4066.
Liu J.,Ma’ayeh S., Peirasmaki D., Lundstrom-Stadelmann B., Hellman L., and Svard S.( 2018). Secreted Giardia intestinalis cysteine proteases disrupt intestinal epithelial cell junctional complexes and degrade chemokines. Virulence. 9: 879–894.
Maloy K.,and Powrie F.(2011).Intestinal homeostasis and its breakdown in inflammatory bowel disease .Nature. 474(7351):298–306.
Moon C., Cheon J., Shin J., Jeon S., Bok H., Lee J.( 2010).Prediction of free bowel perforation in patients with intestinal Behcet’s disease using clinical and colonoscopic findings. Dig Dis Sci.55: 2904–2911.
Pacheco F., Carvalho S.,Cardoso, L.,Andrade L.S.,das Chagas G., Gomes D., Merces C., Rocha F., Silva L., and Soares N.( 2019). Immune response markers in sera of children infected with Giardia duodenalis AI and AII subassemblages. Immunobiology.224:595–603.
Papamichael K., Panagiotis K., and Gerassimos J . .(2014).Helicobacter pylori infection and inflammatory bowel disease: WJG 20th Anniversary Special Issues (6): Helicobacter pylori .World J Gastroenterol ; 20(21): 6374-6385.
Piodi L., Bardella M., and Rocchia C.(2003). Possible protective effect of 5-aminosalicylic acid on Helicobacter pylori infection in patients with inflammatory bowel disease. J Clin Gastroenterol ;36:22–5.
Rhodes D. Y., and Wallace M. (2006).Post-infectious irritable bowel syndrome,‖ Current Gastroenterology Reports ; 8(4): 327–332.
Saghaug C., Sornes S., Peirasmaki D.,Svard S., Langeland N., and Hanevik K.( 2016). Human memory CD4+ T cell immune responses against Giardia lamblia. Clin. Vaccine Immunol. 23, 11–18.
Salman Y J, Sadek W S and Rasheed Z KH.(2015). Prevalence of Cryptosporidium parvum among Iraqi displaced people in Kirkuk city using direct microscopy, flotation technique and ELISA copro-antigen. Int.J.Curr.Microbiol.App.Sci, 4(11): 559-572.
Salman Y. J., Ali C.H. and Abdul-Razaq A.A.(2017). Fecal calprotectin among patients infected with some protozoan infections .Int.J.Curr.Microbiol.App.Sci ; 6(6): 3258-3274.
Salman YJ, Al-taee AA and Abid AM.(2016). Prevalence of Giardia lamblia among Iraqi Displaced People in Kirkuk Province . Int.J.Curr.Microbiol.App.Sci, 2016 , 5(1): 753-760.
Singer S.( 2016).Control of Giardiasis by Interleukin-17 in humans and mice. Clin. Vaccine Immunol.,23, 2–5.
Sonnenberg A.(2013). Review article: historic changes of Helicobacter pylori-associated diseases. Aliment Pharmacol Ther ; 38: 329-342 .
Suryasa, I. W., Rodríguez-Gámez, M., & Koldoris, T. (2021). The COVID-19 pandemic. International Journal of Health Sciences, 5(2), vi-ix. https://doi.org/10.53730/ijhs.v5n2.2937
Tepler A., Narula N., and Peek RM J.(2019). Systematic review with meta-analysis: association between Helicobacter pylori CagA seropositivity and odds of inflammatory bowel disease. Aliment Pharmacol Ther ;50:121-131.
Turki , N.M. ; Mallah , M.O. ; Kremsh ,Y.D. (2015). Iraqi genotyping of The orphan nuclear receptor RORgammat directs the di_erentiation program of proinflammatory IL-17+ T helper cells. Cell. 126:1121–1133.
Wu X.,Ji H., Yang M.(2015). Helicobacter pylori infection and inflammatory bowel disease in Asians: a meta-analysis. World J Gastroenterol ;21:4750–6.
Ximenez C, Mor P,´. Rojas An Valadez A and´ omez A G.(2009). Reassessment of the epidemiology of amebiasis: state of the art,‖ Infection, Genetics and Evolution; 9(6): 1023– 1032
Yu Y., Zhu S., Li P., Min L., Zhang S. (2018).Helicobacter pylori infection and inflammatory bowel disease: a crosstalk between upper and lower digestive tract. Cell Death Dis ;9:961.
Yu Z., Lin L., and Hu Z.(2018). Intestinal Giardiasis Disguised as Ulcerative Colitis.Case Reports in GastrointestinalMedicine:1-3.
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.








